XPO1-dependent nuclear export as a target for cancer therapy
2020 · Journal of Hematology & Oncology · 232 citations
https://doi.org/10.1186/s13045-020-00903-4
Y
Yulin Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
139
Papers
1.7K
Citations
19
h-index
36
i10-index
Yulin Li is an academic researcher from Guilin Medical University. The author has contributed to research in topics: Marine Sponges and Natural Products & Synthetic Organic Chemistry Methods & RNA modifications and cancer. The author has an h-index of 19, co-authored 119 publications.
ORCID: 0000-0003-3479-9909Papers by this author
worksmTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
2022 · Nature Communications · 59 citations
https://doi.org/10.1038/s41467-022-34890-6
Transcriptome-wide N6-methyladenosine (m6A) methylation in watermelon under CGMMV infection
2021 · BMC Plant Biology · 48 citations
https://doi.org/10.1186/s12870-021-03289-8
Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
2019 · Journal of Hematology & Oncology · 30 citations
https://doi.org/10.1186/s13045-019-0803-9
First total synthesis and absolute configuration of marine cembrane diterpenoid (+)-11,12-epoxysarcophytol A
2000 · Tetrahedron Letters · 19 citations
https://doi.org/10.1016/s0040-4039(00)00129-5
Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index
2019 · Scientific Reports · 18 citations
https://doi.org/10.1038/s41598-019-53290-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat